跳至主要内容
临床试验/NCT05237908
NCT05237908进行中(未招募)不适用

Prospective, Randomized, Single-Blind Study for the Evaluation of the Clinical Outcome and the Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages in Transforaminal Lumbar Interbody Fusion

Aesculap AG2 个研究点 分布在 1 个国家目标入组 78 人开始时间: 2022年2月18日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Aesculap AG
入组人数
78
试验地点
2
主要终点
Clinical outcome measured with the Oswestry Disability Index

研究概览

简要总结

Prospective, Randomized, Single-Blind Study for the Evaluation of the Clinical Outcome and the Fusion Rate of 3D Printed Interbody Fusion Cages and Titanium Coated PEEK Cages in Transforaminal Lumbar Interbody Fusion

详细描述

This clinical study is a regulatory Post Market Clinical Follow-Up (PMCF) measure and is aiming to collect clinical data on the performance and safety of the TSPACE® 3D implants. It is designed as a prospective, randomized, single-blind, non-interventional study in order to gain clinical data within the routine clinical application of the investigational device.

The study shall answer the question if there are detectable differences between the established titanium coated Polyether Ether Ketone (PEEK) cages of the manufacturer and the new 3D printed cages. Differences shall be observed in terms of clinical outcome, quality of life, patient satisfaction, radiological outcome and occurrence of Adverse Events / Serious Adverse Events.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Indication for one, two or three-segment lumbar interbody fusion according to Instructions for use
  • Written informed consent for the documentation of clinical and radiological results
  • Willingness and mental ability to participate at the follow-up examinations

排除标准

  • Patient is not willing or able to participate at the follow-up examination
  • Patient age < 18 years and >80 years
  • Patient is pregnant
  • Previous instrumented lumbar spine surgery

结局指标

主要结局

Clinical outcome measured with the Oswestry Disability Index

时间窗: 1 year postoperatively

The Oswestry Disability Index is designed to measure back-specific disability. The questionnaire is self-administered and has 10 items concerning pain and activities of daily living including personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and travelling. It is a self-administered questionnaire Each section is scored on a 0-5 scale, 5 is for maximum disability. The index is calculated by dividing the total score by the total possible score, which is multiplied by 100 and expressed as a percentage. The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100). Zero is equated with no disability and 100 is the maximum disability possible.

次要结局

  • Clinical improvement: pain(preoperatively, at 3 months, 1 year, 2 years and 5 years postoperatively)
  • Radiological outcome: Fusion(1 year postoperatively)
  • Development of Clinical outcome measured with the Oswestry Disability Index(preoperatively, at 3 months, 1 year, 2 years and 5 years postoperatively.)
  • Development Quality of life (EQ-5D-5L)(preoperatively, at 3 months, 1 year, 2 years and 5 years postoperatively)
  • Radiological outcome: Implant subsidence(1 year postoperatively)
  • Radiological outcome: Implant migration(1 year postoperatively)
  • Rate of (Serious) adverse events(throughout the studies duration up to five years postoperatively)

研究者

发起方
Aesculap AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验